Golf’s PGA Tour has entered into a partnership with Cologuard, the at-home colon cancer screening test of molecular diagnostics company Exact Sciences.
The three-year agreement names Cologuard as the official colon cancer screening sponsor of the PGA Tour and PGA Tour Champions, the circuit for senior players.
The partnership grants Cologuard global marketing rights until 2020 and is designed to raise awareness of colon cancer.
The Cologuard test is manufactured by Exact Sciences, which last year became title sponsor of the PGA Tour Champions event in Tucson, Arizona. Through the new agreement, players, tournaments, title sponsors, fans and PGA Tour staff will be challenged to take part in a season-long pledge program to get screened for colon cancer.
Through Cologuard, Exact Sciences will create an on-site presence at a number of PGA Tour Champions events to encourage screening for average-risk adults aged 50 and over to raise awareness about colon cancer.
PGA Tour Champions president Greg McLaughlin said: “Colon cancer awareness is an important societal discussion, and one our players will look to further with this relationship. Today’s announcement allows the Tour to create a more concrete foundation from which to develop those efforts.”
Kevin Conroy, chairman and chief executive of Exact Sciences, added: “The PGA Tour is a tremendous supporter of our efforts to help raise awareness about the most preventable yet least prevented cancer. More than one in three Americans are not current with their colon cancer screening. With the help of Cologuard, ambassador Jerry Kelly, and the PGA Tour, we are committed to ensuring more people get screened.”